These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 6605118

  • 1. Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features.
    Delamere JP, Jobson S, Mackintosh LP, Wells L, Walton KW.
    Ann Rheum Dis; 1983 Oct; 42(5):500-4. PubMed ID: 6605118
    [Abstract] [Full Text] [Related]

  • 2. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
    Garlepp MJ, Dawkins RL, Christiansen FT.
    Br Med J (Clin Res Ed); 1983 Jan 29; 286(6362):338-40. PubMed ID: 6402089
    [Abstract] [Full Text] [Related]

  • 3. [Myasthenia induced by D-penicillamine. Apropos of 2 case reports].
    Huaux JP, Delreux V.
    Acta Neurol Belg; 1986 Jan 29; 86(5):297-303. PubMed ID: 3492852
    [Abstract] [Full Text] [Related]

  • 4. D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence?
    Andonopoulos AP, Terzis E, Tsibri E, Papasteriades CA, Papapetropoulos T.
    Clin Rheumatol; 1994 Dec 29; 13(4):586-8. PubMed ID: 7697959
    [Abstract] [Full Text] [Related]

  • 5. D-penicillamine induced myasthenia gravis: clinical, serological and genetic findings.
    Drosos AA, Christou L, Galanopoulou V, Tzioufas AG, Tsiakou EK.
    Clin Exp Rheumatol; 1993 Dec 29; 11(4):387-91. PubMed ID: 8403583
    [Abstract] [Full Text] [Related]

  • 6. Penicillamine-induced ocular myasthenia gravis.
    O'Keefe M, Morley KD, Haining WM, Smith A.
    Am J Ophthalmol; 1985 Jan 15; 99(1):66-7. PubMed ID: 3966521
    [Abstract] [Full Text] [Related]

  • 7. Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.
    Bucknall RC, Dixon A St J, Glick EN, Woodland J, Zutshi DW.
    Br Med J; 1975 Mar 15; 1(5958):600-2. PubMed ID: 1125624
    [Abstract] [Full Text] [Related]

  • 8. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A, Zilko PJ, Major GA, Tait BD, Property DN, Mathews JD, Hannah MC, McCluskey J, Muirden KD.
    J Rheumatol; 1986 Apr 15; 13(2):269-73. PubMed ID: 3459889
    [Abstract] [Full Text] [Related]

  • 9. D-penicillamine and the ocular myasthenic syndrome.
    Kimbrough RL, Mewis L, Stewart RH.
    Ann Ophthalmol; 1981 Oct 15; 13(10):1171-2. PubMed ID: 7316342
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Penicillamine-induced myasthenia gravis].
    Dtsch Med Wochenschr; 1983 Sep 30; 108(39):1499. PubMed ID: 6578008
    [No Abstract] [Full Text] [Related]

  • 12. [Myasthenia syndrome after peroral treatment with penicillamine].
    Francois J, Verbraeken H, Gabriel P, Wille C.
    Ophthalmologica; 1978 Sep 30; 177(2):88-91. PubMed ID: 745827
    [Abstract] [Full Text] [Related]

  • 13. [Myasthenia induced by D-penicillamine during the treatment of rheumatoid polyarthritis].
    Carter H, Job-Deslandre C, Delrieu F, Kahan A, Menkès CJ.
    Rev Rhum Mal Osteoartic; 1986 May 30; 53(5):341-4. PubMed ID: 3738397
    [Abstract] [Full Text] [Related]

  • 14. Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis.
    Raynauld JP, Lee YS, Kornfeld P, Fries JF.
    J Rheumatol; 1993 Sep 30; 20(9):1592-3. PubMed ID: 8164222
    [Abstract] [Full Text] [Related]

  • 15. Penicillamine-induced myasthenia gravis in a patient with rheumatoid arthritis. A case report.
    Naidoo PD.
    S Afr Med J; 1981 Sep 19; 60(12):478. PubMed ID: 7280897
    [Abstract] [Full Text] [Related]

  • 16. Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis.
    Schiff B, Mizrachi Y, Orgad S, Yaron M, Gazit E.
    Ann Rheum Dis; 1982 Aug 19; 41(4):403-4. PubMed ID: 6981387
    [Abstract] [Full Text] [Related]

  • 17. HLA system and penicillamine induced pemphigus in nine cases of rheumatoid arthritis.
    Bauer-Vinassac D, Menkes CJ, Muller JY, Escande JP.
    Scand J Rheumatol; 1992 Aug 19; 21(1):17-9. PubMed ID: 1570481
    [Abstract] [Full Text] [Related]

  • 18. [D-penicillamine-induced myasthenia gravis].
    Frey RA, Keller F, Michel BA.
    Schweiz Med Wochenschr; 1994 May 21; 124(20):852-6. PubMed ID: 8209208
    [Abstract] [Full Text] [Related]

  • 19. [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
    Rodat O, Hamelin JP, Rossard A, Cottin S, Cler JM, Rodat G, Lemouroux P.
    Nouv Presse Med; 1981 May 02; 10(20):1645-8. PubMed ID: 7255126
    [Abstract] [Full Text] [Related]

  • 20. T cell responses to D-penicillamine in drug-induced myasthenia gravis: recognition of modified DR1:peptide complexes.
    Hill M, Moss P, Wordsworth P, Newsom-Davis J, Willcox N.
    J Neuroimmunol; 1999 Jun 01; 97(1-2):146-53. PubMed ID: 10408968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.